AAAAAA
Results:
1-15
|
Results: 15
Authors:
Trimble, EL
Rowland, J
Varricchio, C
Gore-Langton, RE
Citation: El. Trimble et al., Health-related quality of life in cancer clinical trials, ONCOLOGY-NY, 15(4), 2001, pp. 456
Authors:
Trimble, EL
Rowland, J
Varricchio, C
Gore-Langton, RE
Citation: El. Trimble et al., Clinical trials - Referral resource, ONCOLOGY-NY, 15(4), 2001, pp. 456-456
Authors:
Rowland, JH
Varricchio, CG
Trimble, EL
Gore-Langton, RE
Citation: Jh. Rowland et al., Clinical trials referral resource - Investigator-initiated health-related quality-of-life research, ONCOLOGY-NY, 15(10), 2001, pp. 1284
Authors:
Trimble, EL
Citation: El. Trimble, Prospects for improving staging of ovarian cancers, LANCET, 357(9251), 2001, pp. 159-160
Authors:
Bristow, RE
Asrari, F
Trimble, EL
Montz, FJ
Citation: Re. Bristow et al., Extended surgical staging for uterine papillary serous carcinoma: Survivaloutcome of locoregional (Stage I-III) disease, GYNECOL ONC, 81(2), 2001, pp. 279-286
Authors:
Trimble, EL
Citation: El. Trimble, A guest editorial: Update on diethylstilbestrol, OB GYN SURV, 56(4), 2001, pp. 187-189
Authors:
Trimble, CL
Trimble, EL
Citation: Cl. Trimble et El. Trimble, Update on low malignant potential ovarian tumors, ONCOLOGY-NY, 14(6), 2000, pp. 907-908
Authors:
Trimble, EL
Citation: El. Trimble, Saving the lymph nodes, EUR J GYN O, 21(1), 2000, pp. 13-16
Authors:
Trimble, EL
Citation: El. Trimble, Innovative therapies for advanced ovarian cancer, SEMIN ONCOL, 27(3), 2000, pp. 24-30
Authors:
Bristow, RE
Duska, LR
Lambrou, NC
Fishman, EK
O'Neill, MJ
Trimble, EL
Montz, FJ
Citation: Re. Bristow et al., A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography, CANCER, 89(7), 2000, pp. 1532-1540
Authors:
Steller, MA
Egorin, MJ
Trimble, EL
Bartlett, DL
Zuhowski, EG
Alexander, HR
Dedrick, RL
Citation: Ma. Steller et al., A pilot phase I trial of continuous hyperthermic peritoneal perfusion withhigh-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer (vol 43, pg 106, 1999), CANC CHEMOT, 44(1), 1999, pp. 90-90
Authors:
Steller, MA
Egorin, MJ
Trimble, EL
Bartlett, DL
Zuhowski, EG
Alexander, HR
Dedrick, RL
Citation: Ma. Steller et al., A pilot phase I trial of continuous hyperthermic peritoneal perfusion withhigh-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer, CANC CHEMOT, 43(2), 1999, pp. 106-114
Authors:
Cornelison, TL
Trimble, EL
Kosary, CL
Citation: Tl. Cornelison et al., SEER data, corpus uteri cancer: Treatment trends versus survival for FIGO stage 11, 1988-1994, GYNECOL ONC, 74(3), 1999, pp. 350-355
Authors:
Trimble, EL
Citation: El. Trimble, Clinical trials in ovarian cancer: are we doing our best?, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 31-32
Authors:
Trimble, EL
Kosary, C
Park, RC
Citation: El. Trimble et al., Lymph node sampling and survival in endometrial cancer, GYNECOL ONC, 71(3), 1998, pp. 340-343
Risultati:
1-15
|